Cargando…

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

Detalles Bibliográficos
Autores principales:	Titanji, Boghuma, Gavegnano, Christina, Hsue, Priscilla, Schinazi, Raymond, Marconi, Vincent C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033865/ https://www.ncbi.nlm.nih.gov/pubmed/31973607 http://dx.doi.org/10.1161/JAHA.119.014873

Ejemplares similares

Reply to Jorgensen, et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

Vaxxing to elimination: smallpox vaccines as tools to fight mpox
por: Titanji, Boghuma K., et al.
Publicado: (2023)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents
por: Gavegnano, Christina, et al.
Publicado: (2012)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
por: Punch, Emily, et al.
Publicado: (2022)

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
por: Mehta, Puja, et al.
Publicado: (2022)

Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages
por: Mahboubi, Bijan, et al.
Publicado: (2018)

What’s Hot in HIV in 2019—A Basic and Translational Science Summary for Clinicians From IDWeek 2019
por: Titanji, Boghuma, et al.
Publicado: (2020)

Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity
por: Michos, Erin D., et al.
Publicado: (2023)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
por: Gavegnano, Christina, et al.
Publicado: (2019)

Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression
por: Titanji, Boghuma K., et al.
Publicado: (2022)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)

Barriers, Opportunities, and Challenges in Addressing Disparities in Diet‐Related Cardiovascular Disease in the United States
por: Kris‐Etherton, Penny M., et al.
Publicado: (2020)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015)

American‐Style Football and Cardiovascular Health
por: Kim, Jonathan H., et al.
Publicado: (2018)

Impact of Electronic Cigarettes on the Cardiovascular System
por: Qasim, Hanan, et al.
Publicado: (2017)

The Emerging Role of Irisin in Cardiovascular Diseases
por: Fu, Jinjuan, et al.
Publicado: (2021)

Neglecting emerging diseases – monkeypox is the latest price of a costly default
por: Titanji, Boghuma K.
Publicado: (2022)

Role of Semaphorin Signaling During Cardiovascular Development
por: Sun, Qianchuang, et al.
Publicado: (2018)

Cardiovascular Safety Assessment in Cancer Drug Development
por: Oren, Ohad, et al.
Publicado: (2021)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Contemporary Cardiovascular Imaging Methods for the Assessment of At‐Risk Myocardium
por: Wince, W. Benjamin, et al.
Publicado: (2014)

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
por: Kerkelä, Risto, et al.
Publicado: (2015)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair
por: Gartz, Melanie, et al.
Publicado: (2018)

Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk
por: Ying, Wendy, et al.
Publicado: (2018)

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
por: Belzile‐Dugas, Eve, et al.
Publicado: (2021)

Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
por: Velarde, Gladys, et al.
Publicado: (2023)

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature
por: Oskui, Peyman Mesbah, et al.
Publicado: (2013)

Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease
por: Lui, George K., et al.
Publicado: (2014)

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
por: Eapen, Zubin J., et al.
Publicado: (2016)

Artificial Intelligence: Practical Primer for Clinical Research in Cardiovascular Disease
por: Kagiyama, Nobuyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jt3mhr22rm7jmjt3c2dn8gqmul